243 related articles for article (PubMed ID: 23501101)
21. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
Robinson RA; Lu X; Jones EY; Siebold C
Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
[TBL] [Abstract][Full Text] [Related]
22. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
23. Dimerization of the core domain of the p53 family: a computational study.
Madhumalar A; Jun LH; Lane DP; Verma CS
Cell Cycle; 2009 Jan; 8(1):137-48. PubMed ID: 19106606
[TBL] [Abstract][Full Text] [Related]
24. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
25. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
26. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
28. Structural diversity of p63 and p73 isoforms.
Osterburg C; Dötsch V
Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
[TBL] [Abstract][Full Text] [Related]
29. One billion years of p53/p63/p73 evolution.
Belyi VA; Levine AJ
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17609-10. PubMed ID: 19826090
[No Abstract] [Full Text] [Related]
30. p63 and p73, the ancestors of p53.
Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
[TBL] [Abstract][Full Text] [Related]
31. Evolution of the p53-MDM2 pathway.
Åberg E; Saccoccia F; Grabherr M; Ore WYJ; Jemth P; Hultqvist G
BMC Evol Biol; 2017 Aug; 17(1):177. PubMed ID: 28774266
[TBL] [Abstract][Full Text] [Related]
32. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
Zhang L; Nie L; Maki CG
Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
[TBL] [Abstract][Full Text] [Related]
33. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
[TBL] [Abstract][Full Text] [Related]
35. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
36. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
[TBL] [Abstract][Full Text] [Related]
37. Structure and function in the p53 family.
Arrowsmith CH
Cell Death Differ; 1999 Dec; 6(12):1169-73. PubMed ID: 10637432
[TBL] [Abstract][Full Text] [Related]
38. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
39. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
40. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]